Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK Trial

NCT07141355 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cardiogenic Shock

Interventions

DIAGNOSTIC_TEST: microcirculation using the video microscopy tool.

Sponsor

University Hospital, Strasbourg, France